AVTX
Avalo Therapeutics Inc
13.60$
-0.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.2% | 40.0% | 89.9% | 88.5% | 87.5% | 92.1% | 91.6% | 91.0% | 91.0% | 90.4% | 88.9% | 83.1% | |
| 34.8% | 35.3% | 89.0% | 86.3% | 83.1% | 89.3% | 90.3% | 33.4% | 21.6% | 13.6% | 25.0% | 17.4% | |
| 34.8% | 35.3% | 89.0% | 86.3% | 83.1% | 89.3% | 90.3% | 89.5% | 89.2% | 84.4% | 82.1% | 81.6% | |
| 5.3% | 0.6% | 0.0% | 0.0% | 1.0% | 0.4% | – | – | – | – | – | – | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 49.2% | 50.0% | 8.5% | 9.7% | 10.7% | 7.0% | 7.6% | 8.3% | 8.4% | 9.0% | 10.5% | 2.1% | |
| 49.8% | 65.2% | 181.7% | 112.6% | 78.6% | 11.7% | 11.5% | 17.4% | 26.8% | 28.7% | 31.6% | 8.6% | |
| 20.5% | 22.0% | 174.3% | 89.0% | 61.6% | 4.6% | 4.1% | 7.3% | 6.4% | 11.1% | 11.6% | 4.3% | |
| 1.8% | 2.6% | 0.4% | 0.5% | 0.6% | 0.4% | 0.4% | 0.4% | 0.4% | 0.3% | 0.3% | 0.0% | |
| 2.7% | 2.1% | 0.7% | 0.6% | 1.8% | 0.2% | 0.5% | 1.9% | 0.4% | 0.1% | 0.4% | 0.7% | |
| 50.2% | 34.8% | -81.7% | -12.6% | 21.4% | 88.3% | 88.5% | 82.6% | 73.2% | 71.3% | 68.4% | 91.4% | |
| -1,117.1% | -1,596.4% | -368.9% | -330.5% | -340.2% | -245.6% | -276.8% | -319.3% | -347.6% | -385.1% | -468.7% | -102.8% | |
| 0.7% | 3.8% | 0.7% | 7.1% | 11.0% | 6.9% | 7.6% | 8.6% | 11.2% | 15.9% | 20.1% | 8.9% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.